(VIANEWS) - Invesco Trust for Investment Grade New York Municipals (VTN), Allianceberstein Holding L.P. Units (AB), Pfizer (PFE) are the highest payout ratio stocks on this list.
We have collected information about stocks with the highest payout ratio up until now. The payout ratio in itself isn't a promise of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. Invesco Trust for Investment Grade New York Municipals (VTN)
2858% Payout Ratio
Invesco Trust for Investment Grade New York Municipals was launched in 2012 by Invesco Ltd. It is closed-ended, fixed income mutual fund. Invesco Advisers, Inc., INVESCO Asset Management Japan Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, INVESCO Asset Management Canada Ltd., Invesco Hong Kong Limited, INVESCO Senior Secured Management, Inc. manage the fund. The fund invests in fixed income markets across the United States. It invests primarily in New York's investment-grade municipal securities, which includes municipal bonds, municipal commercial papers, and lease obligations. To create its portfolio, it combines fundamental analysis and a bottom-up security selection process. The former name of the fund was Invesco Van Kampen trust for investment grade New York municipals. Invesco Trust for Investment Grade New York Municipals, which was established on March 27, 1992, is based in the United States.
Volume
Today's last reported volume for Invesco Trust for Investment Grade New York Municipals is 27582, 20.15% below its average volume of 34545.
As stated by Morningstar, Inc., the next dividend payment is on Sep 13, 2022, the estimated forward annual dividend rate is 0.51 and the estimated forward annual dividend yield is 4.86%.
Year-on-year quarterly revenue growth declined by 10.6%, now sitting on 14.84M for the twelve trailing months.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.17%.
Volatility
Invesco Trust for Investment Grade New York Municipals's last day, week, and month's current intraday variation average was 1.17%, 0.52%, and 0.69%, respectively.
Invesco Trust for Investment Grade New York Municipals's highest amplitude of average volatility was 1.17% (day), 1.32% (last week), and 1.42% (last month), respectively.
Invesco Trust for Investment Grade New York Municipals's Stock Yearly Top and Bottom Value
Invesco Trust for Investment Grade New York Municipals's stock is valued at $10.27 at 08:23 EST, way below its 52-week high of $13.94 and higher than its 52-week low of $10.06.
Invesco Trust for Investment Grade New York Municipals's Moving Average
Invesco Trust for Investment Grade New York Municipals's worth is below its 50-day moving average of $10.83 and way under its 200-day moving average of $11.63.2. Allianceberstein Holding L.P. Units (AB)
107.26% Payout Ratio
AllianceBernstein Holding L.P., a publicly-owned investment manager, is a subsidiary of AllianceBernstein Holding L.P. It also offers research services for its clients. The firm provides services for investment companies, profit and pension sharing plans, banks, thrift institutions, trusts and estates, government agencies and charitable organizations as well as individuals and corporations. It invests in fixed income and public equity markets around the world. The firm uses a long- and short-term strategy for making its investments. To make investments, the firm does its own research. AllianceBernstein Holding L.P., which was established in 1987 is located in New York.
Volume
Today's last reported volume for Allianceberstein Holding L.P. Units is 170001, 33.99% below its average volume of 257570.
As maintained by Morningstar, Inc., the next dividend payment is on Aug 4, 2022, the estimated forward annual dividend rate is 3.79 and the estimated forward annual dividend yield is 8.47%.
Allianceberstein Holding L.P. Units's sales growth this year is anticipated to be negative 5.7% and 4.5% for next year.
Year-on-year quarterly revenue growth declined by 22.6%, now sitting on 399.72M for the twelve trailing months.
Allianceberstein Holding L.P. Units's sales growth for the next quarter is negative 14.9%. The company's growth estimates for the present quarter and the next is negative 29.2% and negative -42.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24%.
Volatility
Allianceberstein Holding L.P. Units's last day, week, and month's current intraday variation average was 1.13%, 0.88%, and 0.88%, respectively.
Allianceberstein Holding L.P. Units's highest amplitude of average volatility was 1.33% (day), 2.45% (last week), and 2.22% (last month), respectively.
Allianceberstein Holding L.P. Units's Stock Yearly Top and Bottom Value
Allianceberstein Holding L.P. Units's stock is valued at $43.98 at 08:23 EST, way under its 52-week high of $57.54 and way higher than its 52-week low of $35.20.
Allianceberstein Holding L.P. Units's Moving Average
Allianceberstein Holding L.P. Units's worth is above its 50-day moving average of $42.93 and below its 200-day moving average of $44.78.3. Pfizer (PFE)
35.36% Payout Ratio
Pfizer Inc. develops and markets biopharmaceutical products in the world. The company offers medicines and vaccines across a variety of therapeutic areas. It also sells biologics and small molecules under the Eliquis and Premarin brands. It also offers vaccines and medicines in a variety of therapeutic areas such as meningococcal and pneumococcal diseases, tick-borne encephalitis and COVID-19 under Comirnaty/BNT162b2 and Trumenba brands. Biosimilars are available for chronic immuno-inflammatory and inflammatory conditions under the Xeljanz/Vyndamax and BeneFIX brands. The company also has a contract manufacturing division. The company serves pharmacies and individuals, along with government agencies and hospitals. Collaboration agreements were signed with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics, Inc., Merck KGaA, Valneva SE, BioNTech SE, and Arvinas, Inc. Pfizer Inc. is headquartered New York, New York.
Volume
Today's last reported volume for Pfizer is 12719300, 30.88% below its average volume of 18403300.
As stated by Morningstar, Inc., the next dividend payment is on May 11, 2022, the estimated forward annual dividend rate is 1.6 and the estimated forward annual dividend yield is 3.21%.
Pfizer's sales growth this year is expected to be 28.8% and a negative 25.2% for next year.
Year-on-year quarterly revenue growth grew by 106.8%, now sitting on 81.29B for the twelve trailing months.
Pfizer's sales growth is 40.9% for the current quarter and 8.9% for the next. The company's growth estimates for the ongoing quarter and the next is 89.7% and 41%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.87%.
Volatility
Pfizer's last day, week, and month's current intraday variation average was 0.09%, 1.43%, and 1.45%, respectively.
Pfizer's highest amplitude of average volatility was 1.38% (day), 1.95% (last week), and 2.21% (last month), respectively.
Pfizer's Stock Yearly Top and Bottom Value
Pfizer's stock is valued at $46.15 at 08:24 EST, way below its 52-week high of $61.71 and way above its 52-week low of $38.82.
Pfizer's Moving Average
Pfizer's worth is below its 50-day moving average of $50.59 and below its 200-day moving average of $50.24.Previous days news about Pfizer (PFE)
- According to FXStreet on Wednesday, 14 September, "Moderna has reportedly filed a lawsuit against Pfizer (PFE) and BioNTech (BNTX) for patent infringement involving cold vaccine development in the US.", "Moderna says in its lawsuit that Pfizer and BioNTech's COVID-19 vaccine Comirnatyinfringes on patents that Moderna filed between 2010 and 2016 covering mRNA technology."
4. Parker (PH)
31.81% Payout Ratio
Parker-Hannifin Corporation produces and sells motion control technology and systems worldwide. Two segments of the company are Diversified Industrial and Aerospace Systems. Diversified Industrial offers sealant, shielding and thermal products, as well as adhesives, coatings and noise vibration and harshness. The segment is sold to OEMs and distributors that serve replacement markets for manufacturing, packaging and processing. The Aerospace Systems segment includes products that can be used in military and commercial aircraft and engine programs. These include control actuation system and components as well as engine exhaust nozzles. Fluid conveyance systems are also available. Fuel systems and parts, fuel systems systems, inerting systems, hydraulics systems, components, fuel tanks, fuel systems, hydraulics systems and other components. Lubrication and components for pilot controls and pneumatic control elements, thermal management products and wheels. The segment sells its products to OEMs as well as end-users. The company markets its products via direct sales employees, independent distributors and sales reps. Cleveland is the headquarters of this company, which was established in 1917.
Volume
Today's last reported volume for Parker is 432094, 43.11% below its average volume of 759653.
As maintained by Morningstar, Inc., the next dividend payment is on May 11, 2022, the estimated forward annual dividend rate is 5.32 and the estimated forward annual dividend yield is 2%.
Parker's sales growth this year is expected to be 9.8% and 5.6% for next year.
Year-on-year quarterly revenue growth grew by 12.1%, now sitting on 15.29B for the twelve trailing months.
Parker's sales growth for the current quarter is 3.2%. The company's growth estimates for the ongoing quarter and the next is 7.1% and 5.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.87%.
Volatility
Parker's last day, week, and month's current intraday variation average was 0.18%, 2.14%, and 1.50%, respectively.
Parker's highest amplitude of average volatility was 2.04% (day), 2.30% (last week), and 2.37% (last month), respectively.
Parker's Stock Yearly Top and Bottom Value
Parker's stock is valued at $269.75 at 08:25 EST, way under its 52-week high of $340.00 and way higher than its 52-week low of $230.44.